BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35155190)

  • 1. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
    Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
    Front Oncol; 2021; 11():784289. PubMed ID: 35155190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
    Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
    Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer.
    Tu Z; Tian T; Chen Q; Li C
    J Oncol; 2021; 2021():8052752. PubMed ID: 34335761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients.
    Li X; Zhang C; Sun Z; Yang F; Xiao R; Sui X; Jiang G; Zhong W; Wang J
    Lung Cancer; 2019 Jul; 133():75-82. PubMed ID: 31200832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of adjuvant chemotherapy on patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Kim BG; Choi J; Lee SK; Choi SI; Park CK; Sim JK; Lee H; Kim SH; Sohn JW; Yoon HJ; Lee SY; Park DW
    J Thorac Dis; 2024 Feb; 16(2):875-883. PubMed ID: 38505035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis.
    Zhou K; Zhao Y; Liang L; Cao J; Lin H; Peng Z; Mei J
    Front Oncol; 2022; 12():938195. PubMed ID: 36119504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size.
    Huang W; Deng HY; Lin MY; Xu K; Zhang YX; Yuan C; Zhou Q
    Front Oncol; 2022; 12():830470. PubMed ID: 35280762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Nomogram for Identifying Candidates for Adjuvant Chemotherapy in Patients With Stage IB Non-small Cell Lung Cancer.
    Song X; Xie Y; Deng H; Yu F; Wang S; Lou Y
    Cancer Control; 2023; 30():10732748231177541. PubMed ID: 37204026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non-small cell lung cancer.
    Wo Y; Zhao Y; Qiu T; Li S; Wang Y; Lu T; Qin Y; Song G; Miao S; Sun X; Liu A; Kong D; Dong Y; Leng X; Du W; Jiao W
    Cancer Med; 2019 Feb; 8(2):669-678. PubMed ID: 30706688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pleural invasion on survival of patients with small cell lung cancer: Propensity score analysis and nomogram establishment based on the SEER database.
    Yang J; Yin H; Liu M; Zou G; Yu B
    Front Surg; 2023; 10():1108732. PubMed ID: 36911624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Nomogram to Predict the Overall Survival of Patients With Resected T1-2N0-1M0 Non-Small Cell Lung Cancer and to Identify the Optimal Candidates for Adjuvant Chemotherapy in Stage IB or IIA Non-Small Cell Lung Cancer Patients.
    Wang W; Zhou J
    Cancer Control; 2023; 30():10732748231197973. PubMed ID: 37703536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of visceral pleural invasion in the stage pT
    Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
    Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of pleural invasion for resected NSCLC patients undergoing adjuvant treatments: A propensity score-matched analysis of SEER database.
    De Giglio A; Di Federico A; Gelsomino F; Ardizzoni A
    Lung Cancer; 2021 Nov; 161():18-25. PubMed ID: 34492552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
    Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
    J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.
    Zhang Z; Xie S; Cai W; Hong ZN; Yang C; Lin Y; Zhu J; Lin Z; Christoph DC; Bohnenberger H; Kepka L; Brueckl WM; Van Houtte P; Kang M; Lin J
    Transl Lung Cancer Res; 2022 Jan; 11(1):75-86. PubMed ID: 35242629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram to Predict Cancer Specific Survival in Patients with Pathological Stage IA Non-small Cell Lung Cancer.
    Cai JS; Dou XM; Li JB; Yang MZ; Xie CL; Hou X; Yang HX
    Semin Thorac Cardiovasc Surg; 2022; 34(3):1040-1048. PubMed ID: 34216749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do older patients with stage IB non-small-cell lung cancer obtain survival benefits from surgery? A propensity score matching study using SEER data.
    Ye X; Liu Y; Yang J; Wang Y; Cui X; Xie H; Song L; Ding Z; Zhai R; Han Y; Yang L; Zhang H
    Eur J Surg Oncol; 2022 Sep; 48(9):1954-1963. PubMed ID: 35379544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB-IIA Lung Adenocarcinoma.
    Zhai W; Gong L; Zheng Y; Yan Q; Lai R; Liang D; Wong W; Dai S; Wang J
    Front Oncol; 2022; 12():851276. PubMed ID: 35402251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC.
    Shen ZQ; Feng KP; Fang ZY; Xia T; Pan S; Ding C; Xu C; Ju S; Chen J; Li C; Zhao J
    J Cardiothorac Surg; 2024 Jan; 19(1):1. PubMed ID: 38166960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.